Dr. Jennifer Cudris Maldonado, MD

Dr. Cudris Maldonado practices at The Oncology Institute of Hope and Innovation - Brandon in Cerritos, California.

Dr. Cudris Maldonado's NPI, 1831308022, was assigned on May 22, 2007. Dr. Cudris Maldonado graduated from Pontifical Xavierian University in 2002. Dr. Cudris Maldonado holds Florida license 130149.

Dr. Cudris Maldonado's primary practice is The Oncology Institute of Hope and Innovation - Brandon, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 699-3970.

Dr. Cudris Maldonado's primary practice is The Oncology Institute of Hope and Innovation - Brandon in Cerritos, California. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Cudris Maldonado to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cudris Maldonado practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cudris Maldonado's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cudris Maldonado is board certified in hematology by the American Board of Internal Medicine. Dr. Cudris Maldonado is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Cudris Maldonado treats.

CMS data shows 37 Medicare services from Dr. Cudris Maldonado across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $2,479 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Cudris Maldonado in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cudris Maldonado's median patient age at 64, with 65% women.

In 2024, Dr. Cudris Maldonado wrote 404 Medicare Part D claims for 90 patients. 68% of them were for generic drugs. CMS names the drug for 250 of them, across 10 drugs with 11 or more claims each, at $624,468 in total drug cost. In 2023, CMS named 359 claims across 18 drugs.

Dr. Cudris Maldonado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 627 general payments to Dr. Cudris Maldonado from 75 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 77% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,133.

Dr. Cudris Maldonado graduated from Pontifical Xavierian University in 2002.

Dr. Cudris Maldonado is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.